I realize this may be a futile attempt on my part to put a positive spin on NXTM earnings report. Yes, the market dropped like a lead ball today. My answer to that is "the market giveth and the market taketh away". No, I'am not one of those guys who see the glass half empty, I just try to keep my emotions in check, after all this is the stock market! There are those who have complain about a lack of information ( self included)concerning NXTM. I for one did not realize they have 3 different revenue streams which did well compared to this time last year Q2 2010.
Home review (Home dialysis, portable) up 30% Critical care revenue up 29% In-Center revenues (Medisystem business) up 10%
Basically what all this means in a nut shell, Nxstage Q2 2011 is up 22% compared to Q2 2010. Plus there ovrall debt was reduced to $5.6 mil from Q2 2010 debt of $8.3...
Also, this is word for word....... Nxstage announced that it recently concluded its renegotiation of its United States home market agreement with one its largest customers and signed an amendment to that agreeement, extending the term to December 31, 2012, and up to one additional year thereafter. This amended agreement covers the use of NxStage's products for home hemodialysis.
Hopefully, this gives all of us some insight. The product provided by this company is most important. The nearest competitor to the NXTM FDA approved portable hemodialysis units are still several year away as so stated in the article. source: Yahoo finance/ headlines.